V 150 (Kalydeco 150 mg)

Generic Name: ivacaftor

Pill imprint V 150 has been identified as Kalydeco 150 mg.

Kalydeco is used in the treatment of cystic fibrosis and belongs to the drug class CFTR potentiators. There is no proven risk in humans during pregnancy. Kalydeco 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for V 150

Kalydeco 150 mg V 150
Kalydeco
Generic Name:
ivacaftor
Imprint:
V 150
Strength:
150 mg
Color:
Blue
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CFTR potentiators
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Vertex Pharmaceuticals Inc.
National Drug Code (NDC):
51167-0200
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
hypromellose acetate succinate 06081224 (3 mm2/s)
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
carnauba wax
FD&C Blue No. 2
polyethylene glycol 3350
polyvinyl alcohol
magnesium silicate
titanium dioxide
ammonia
ferrosoferric oxide
propylene glycol
shellac

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)